CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
TRACE focuses on developing multifunctional molecular cages for prostate cancer treatment that combine diagnostic and therapeutic capabilities. By integrating various agents into a single platform, it aims to enhance treatment specificity and efficacy while improving imaging accuracy.
Prostate cancer (PC) is the second most commonly diagnosed cancer in men and a leading cause of mortality.
Current systemic therapies, particularly chemotherapy, often suffer from high toxicity and limited specificity.
Theranostic agents, which combine diagnostic and therapeutic functions in a single platform, enable targeted imaging and treatment when equipped with units that recognize specific biomarkers, offering a promising alternative to conventional approaches.
In PC, the prostate-specific…
UNIVERSITAT ZURICH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
